220 related articles for article (PubMed ID: 31442905)
1. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
[TBL] [Abstract][Full Text] [Related]
2. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
[TBL] [Abstract][Full Text] [Related]
3. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.
Rossier P; Wade DT
Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Brazilian version of Guy's neurological disability scale.
Araujo CR; Simão LM; Ybarra MI; Faria NV; Botelho CM; Moreira MA; Teixeira AL; Lana-Peixoto MA
Arq Neuropsiquiatr; 2007 Sep; 65(3A):615-8. PubMed ID: 17876401
[TBL] [Abstract][Full Text] [Related]
5. Psychometric testing of the Americanized version of the Guy's Neurological Disability Scale.
Fraser C; McGurl J
J Neurosci Nurs; 2007 Feb; 39(1):13-9. PubMed ID: 17396533
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of patient self-report, neurologic examination, and functional impairment in MS.
Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH
Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932
[TBL] [Abstract][Full Text] [Related]
7. The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.
Hoogervorst EL; de Jonge P; Jelles B; Huyse FJ; Heeres I; van der Ploeg HM; Uitdehaag BM; Polman CH
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):20-4. PubMed ID: 12486260
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale.
Pappalardo A; Patti F
Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584
[TBL] [Abstract][Full Text] [Related]
9. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.
Hoogervorst EL; Eikelenboom MJ; Uitdehaag BM; Polman CH
J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):439-42. PubMed ID: 12640058
[TBL] [Abstract][Full Text] [Related]
10. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis.
Sharrack B; Hughes RA
Mult Scler; 1999 Aug; 5(4):223-33. PubMed ID: 10467380
[TBL] [Abstract][Full Text] [Related]
11. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
[TBL] [Abstract][Full Text] [Related]
12. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
13. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
15. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
16. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
[TBL] [Abstract][Full Text] [Related]
17. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cognitive function and body mass index in multiple sclerosis patients.
Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
[TBL] [Abstract][Full Text] [Related]
19. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.
Hoogervorst EL; Kalkers NF; Cutter GR; Uitdehaag BM; Polman CH
Mult Scler; 2004 Feb; 10(1):55-60. PubMed ID: 14760953
[TBL] [Abstract][Full Text] [Related]
20. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.
Siepman TA; Janssens AC; de Koning I; Polman CH; Boringa JB; Hintzen RQ
J Neurol; 2008 Jun; 255(6):910-6. PubMed ID: 18484237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
